Skip to main content
. Author manuscript; available in PMC: 2010 Nov 16.
Published in final edited form as: Exp Cell Res. 2008 Nov 20;315(3):432–450. doi: 10.1016/j.yexcr.2008.11.003

Table 1.

Actions of NF-κB inhibitors on deoxycholyltaurine (DCT)-induced NF-κB nuclear translocation and transcriptional activation in H508 colon cancer cells

Inhibition, % reduction observed with inhibitor plus DCT (100 μM)
Inhibitor Nuclear translocation p Transcriptional activation p
SN50 (20 μg/ml) 92.4±10.2 0.01 75.8±6.8 0.02
MG-132 (50 μM) 85.4±8.7 0.01 82.7±7.3 0.02
BAY11-7082 (10 μM) 70.9±6.4 0.02 60.4±6.1 0.03

H508 cells were incubated for 30 min with 100 μM DCT, alone or with the indicated concentration of NF-κB inhibitor, and nuclear extracts were immunoblotted for the p65 NF-κB subunit. NF-κB transcriptional activation was measured by using a TransAM NF-κB kit. Values are means±SE from three experiments. p indicates comparison of values observed with cells incubated with DCT (100 μM) plus the indicated concentration of NF-κB inhibitor compared to cells incubated with DCT alone.